Category: Drug Development
United States Drug Development
-
U.S. Contract Research Organization (CROs) Market, by Service Type (Drug Discovery, Preclinical studies, Early Phase I – IIa, Phase IIa – III, Phase IIIb – IV, Drug Development, Medical Coding and Writing, Monitoring, Clinical Data Management, Bio-statist
... Management, Bio-statistics, Site Management, Protocol Development, and Biomarker Discovery), by Therapeutic Application (Oncology, Cardiovascular Diseases, Central Nervous System Diseases, Infectious Diseases, Metabolic Disorders, Immunological Disorders, Respiratory Disorders, and Others), and by Size of CRO (Small ... Read More
-
U.S. Biochip Product & Services Market, By Type (Products (Microarrays, Reagents & other Consumables, Others), Services), By Application (Drug Discovery, Life Science Research, IVD Tests, Others) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 20
... 2028 Surgical Equipment are used for diagnosis of infectious diseases, respiratory diseases, cancer, and for personalized treatment. There are three types of biochips namely DNA microarray, protein microarray, and microfluidic chip. Increasing number of clinical ... Read More
-
3D Cell Culture Market, by Technology (Extracellular Matrices or Scaffolds, Bioreactors, Gels, Scaffold-free Platforms, and Microchips), by Application (Research, Drug Discovery, Tissue Engineering, Clinical Applications, and Stem Cell Biology), by End Us
... Institutes, Biopharmaceutical Industry, Hospitals And Diagnostic Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 A 3D ... Read More
-
United States Drug Discovery Market Forecast 2022-2028
... drug discovery and development markets with the presence of several industry players. MARKET INSIGHTS In the United States, cancer and heart disease have been leading death causes for over a decade. Also, the rising prevalence ... Read More
-
U.S. Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User (Pharma Companies, Providers) - Forecast to 2028
... grow at a CAGR of 13.0% from 2021 to 2028 to reach $2.01 billion by 2028 Following a thorough secondary and primary research and in-depth analysis of the market scenario, the report carries out the ... Read More
Research Assistance
